-
GAM: Strong progress in implementing turnaround strategy – continues to target profitability in fiscal year 2026
-
Meier Tobler beendet die erste Tranche des Rückkaufangebots 2025 zum Festpreis
-
ABB ranked second top Swiss company for patent applications in 2024
-
Peach Property portfolio and balance sheet transformation in 2024 – significantly deleveraged balance sheet
-
Peach Property: Portfolio- und Bilanztransformation in 2024 – signifikant entschuldete Bilanz
-
Baloise mit operativ erfolgreichem Geschäftsjahr und höherer Dividende
-
Baloise delivers an operationally successful year and increases its dividend
-
Straumann Group präsentiert ihren fortschrittlichen End-to-End-Workflow für digitale Zahnmedizin auf der IDS in Köln
-
Straumann Group to present its advanced digital dentistry end-to-end workflow at the International Dental Show in Cologne
-
Kühne+Nagel gibt Update zu Strategie und Ausblick am heutigen Kapitalmarkttag
-
Kuehne+Nagel provides update on strategy and outlook at Capital Markets Day today
-
SoftwareOne: Crayon transaction cleared by the Federal Cartel Office for Germany
-
ALSO: Record dividend approved by AGM – +629% since 2011 (from CHF 0.70 to CHF 5.10)
-
Gurit: supplier to the USA Department of Defense – 10 million CHF in sales over a multi-year period
-
Stadler Rail: 2024 wird durch drei Umweltkatastrophen stark belastet – trotzdem rund 500 Fahrzeuge ausgeliefert
-
Temenos issues CHF 250m 5-year bond – annual fixed-rate coupon of 2.22% and matures in April 2030
-
Partners Group to acquire Middle River Power and a 1.9 GW portfolio of natural gas power plants in the US
-
Tecan stable dividend of CHF 3.00 per share -publishes agenda for the Annual General Meeting 2025
-
Vetropack overall result for 2024 is significantly below the prior year’s level
-
Julius Baer to enter Italian onshore market – setting up a dedicated branch in Italy
-
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-EBITDA-Marge von 17 % auf 19 %
-
Ascom: Hellcat ransomware gang compromised technical ticketing system
-
Partners Group to sell Greenlink, a 504 MW subsea electricity interconnector linking Great Britain and Ireland
-
Idorsia: US FDA has fully released Tryvio (aprocitentan) from its REMS (Risk Evaluation and Mitigation Strategy) requirement
-
u-blox to divest Cellular business to Trasna
-
Implenia gewinnt grosses Bahnprojekt in Schweden mit einer Auftragssumme von ca. CHF 130 Mio.
-
Implenia wins major rail project in Sweden worth around CHF 130 million
-
Idorsia: A randomized cross-over trial of daridorexant for the treatment of chronic insomnia and nocturia
-
Basilea: Strong Cresemba (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment
-
Starke Verkaufszahlen für Cresemba (Isavuconazol) in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus
-
Swiss Re proposes increased dividend of USD 7.35 per share, supported by solid results and strong capital position
-
DocMorris prepares capital increase of around CHF 200 million
-
Inficon: Sales USD 671.0, minus 0.4%; Operating profit USD 136.0 million or 20.3% of sales, plus 0.6%
-
Rieter Closes the Financial Year 2024 with a Solid Operating Result
-
Rieter schliesst das Geschäftsjahr 2024 mit solidem operative Ergebnis ab
-
Accelleron breaks through the USD 1 billion revenue mark
-
DocMorris plant Kapitalerhöhung von rund CHF 200 Mio.
-
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma – Obesity drug Petrelintide
